Pancreatic Neuroendocrine Tumor
What's New
Last Posted: Oct 13, 2024
- DAXX is associated with early recurrence of pancreatic neuroendocrine tumors after R0 resection.
Benjamin C Greenspun, et al. Surgery 2024 0 - CTNNB1 exon 3 mutations in metastatic solid pseudopapillary neoplasm of the pancreas.
Andrew M Fleming, et al. Journal of surgical oncology 2024 0 - Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.
Erica S Tsang, et al. JCO precision oncology 2024 0 e2300494 - Targeted deep sequencing reveals the genetic heterogeneity in well-differentiated pancreatic neuroendocrine tumors with liver metastasis.
Wentao Zhou, et al. Hepatobiliary surgery and nutrition 2023 0 (3) 302-313 - Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease.
Tirosh Amit, et al. JAMA oncology 2017 0 (1) 124-126 - Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations.
Boons Gitta, et al. Frontiers in oncology 2018 0 467 - Pilot study of rapid MR pancreas screening for patients with BRCA mutation.
Corrias Giuseppe, et al. European radiology 2019 0 (8) 3976-3985 - Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor.
Goksu Suleyman Yasin, et al. Cancers 2020 0 (9) - High Cancer Susceptibility Candidate 8 Expression Is Associated With Poor Prognosis of Pancreatic Adenocarcinoma: Validated Analysis Based on Four Cancer Databases.
Wang Yingyi, et al. Frontiers in cell and developmental biology 2020 0 392 - The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report.
Aversa John G, et al. BMC cancer 2020 0 (1) 256
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: